TY - JOUR
T1 - Attention-deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases :
T2 - A systematic review and meta-analysis
AU - Li, Lin
AU - Garcia-Argibay, Miguel
AU - Du Rietz, Ebba
AU - Brikell, Isabell
AU - Solmi, Marco
AU - Cortese, Samuele
AU - Ramos-Quiroga, Josep Antoni
AU - Ribases, Marta
AU - Chang, Zheng
AU - Larsson, Henrik
AU - Yao, Honghui
AU - Zhang, Le
N1 - © 2023 The Authors. JCPP Advances published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.
PY - 2023/9
Y1 - 2023/9
N2 - Attention-deficit/hyperactivity disorder (ADHD) often co-occurs with other psychiatric and physical diseases. However, available evidence on associations between ADHD and cardiovascular diseases (CVDs) is mixed. To systematically review, quantitatively synthesize, and appraise available evidence on the link between ADHD with CVDs, we searched relevant articles in PubMed, Embase, PsycINFO, and Web of Science from inception to May 1, 2022. Study quality was assessed by using the Newcastle-Ottawa Scale, and random-effects model meta-analyses were performed. A total of 18,391,169 (ADHD: n = 421,224) individuals from 11 studies were included in our systematic review and 8,196,648 (ADHD = 332,619) individuals from five studies were included in the main meta-analysis of adjusted estimates. Pooled estimates showed that ADHD was significantly associated with an increased risk of CVDs in analyses based on adjusted effect size (odds ratio (OR) = 1.96; 95% confidence interval (CI) = 1.19-2.23, Q = 140.74, P < 0.001, I 2 = 97.2%). When restricted among adults, the heterogeneity declined to null (OR = 1.73; 95% CI = 1.14-2.62, Q = 6.28, P = 0.10, I 2 = 6.28%), suggesting age might be the main source of heterogeneity. In subgroup analyses, we found increased risk of CVDs associated with ADHD across age groups, type of CVDs, and data sources. This systematic review and meta-analyses indicate that ADHD is associated with increased risk for CVDs, but further studies with various study designs are warranted to advance the understanding of the underlying mechanisms for the observed association between ADHD and CVDs. Additional research is also needed to resolve the role of ADHD medications which remains unclear due to the limited number of primary studies exploring this issue. Individuals with ADHD were nearly twice as likely to develop at least one CVD, compare with non-ADHD. The observed strength of associations were largely comparable to estimates of associations between sever mental illness and CVDs.
AB - Attention-deficit/hyperactivity disorder (ADHD) often co-occurs with other psychiatric and physical diseases. However, available evidence on associations between ADHD and cardiovascular diseases (CVDs) is mixed. To systematically review, quantitatively synthesize, and appraise available evidence on the link between ADHD with CVDs, we searched relevant articles in PubMed, Embase, PsycINFO, and Web of Science from inception to May 1, 2022. Study quality was assessed by using the Newcastle-Ottawa Scale, and random-effects model meta-analyses were performed. A total of 18,391,169 (ADHD: n = 421,224) individuals from 11 studies were included in our systematic review and 8,196,648 (ADHD = 332,619) individuals from five studies were included in the main meta-analysis of adjusted estimates. Pooled estimates showed that ADHD was significantly associated with an increased risk of CVDs in analyses based on adjusted effect size (odds ratio (OR) = 1.96; 95% confidence interval (CI) = 1.19-2.23, Q = 140.74, P < 0.001, I 2 = 97.2%). When restricted among adults, the heterogeneity declined to null (OR = 1.73; 95% CI = 1.14-2.62, Q = 6.28, P = 0.10, I 2 = 6.28%), suggesting age might be the main source of heterogeneity. In subgroup analyses, we found increased risk of CVDs associated with ADHD across age groups, type of CVDs, and data sources. This systematic review and meta-analyses indicate that ADHD is associated with increased risk for CVDs, but further studies with various study designs are warranted to advance the understanding of the underlying mechanisms for the observed association between ADHD and CVDs. Additional research is also needed to resolve the role of ADHD medications which remains unclear due to the limited number of primary studies exploring this issue. Individuals with ADHD were nearly twice as likely to develop at least one CVD, compare with non-ADHD. The observed strength of associations were largely comparable to estimates of associations between sever mental illness and CVDs.
KW - Attention-deficit/hyperactivity disorder
KW - Cardiovascular diseases
KW - Meta-analysis
KW - Observational studies
KW - Systematic review
UR - https://www.mendeley.com/catalogue/8c1ef028-1437-3936-9e0d-a9b28b3a543d/
UR - https://www.scopus.com/pages/publications/85171678069
U2 - 10.1002/jcv2.12158
DO - 10.1002/jcv2.12158
M3 - Article
C2 - 37720588
SN - 2692-9384
VL - 3
JO - JCPP Advances
JF - JCPP Advances
IS - 3
ER -